CLINICAL OBSERVATION FROM THE TREATMENT OF ICOTINIB FOR 196 CASES WITH ADVANCED NON-SMALL CELL LUNG CANCER

被引：0
|
作者：
Gu, Qin A. [1 ]
Han, Hui B. [1 ]
Jiang, Yan L. [1 ]
Wang, Min H. [1 ]
Shi, Lei C. [1 ]
Xiong, Wen L. [1 ]
Zhao, Zhuo Y. [1 ]
Chu, Qing T. [1 ]
Pei, Jun [1 ]
机构：
[1] Jiaotong Uniyers, Shanghai Chest Hosp, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
ADVANCED NSCLC; EGFR-TKI; Icotinib;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.11-012
引用
收藏
页码：S598 / S598
页数：1
相关论文
共 50 条
  • [1] Effects of Icotinib on Advanced Non-Small Cell Lung Cancer with Different EGFR Phenotypes
    Pan, Huiyun
    Liu, Rong
    Li, Shengjie
    Fang, Hui
    Wang, Ziwei
    Huang, Sheng
    Zhou, Jianying
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2014, 70 (01) : 553 - 558
  • [2] Observation on the Clinical Effect of Apatinib Combined with Chemotherapy in the Treatment of Advanced Non-Small Cell Lung Cancer
    Cui, Yu-jie
    Liu, Jia
    Liu, Miao-miao
    Zhang, Hong-zhen
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2021, 37 (04) : 1036 - 1041
  • [3] Efficacy and safety evaluation of icotinib in patients with advanced non-small cell lung cancer
    Gu, Aiqin
    Shi, Chunlei
    Xiong, Liwen
    Chu, Tianqing
    Pei, Jun
    Han, Baohui
    CHINESE JOURNAL OF CANCER RESEARCH, 2013, 25 (01) : 90 - 94
  • [4] Effects of Icotinib on Advanced Non-Small Cell Lung Cancer with Different EGFR Phenotypes
    Huiyun Pan
    Rong Liu
    Shengjie Li
    Hui Fang
    Ziwei Wang
    Sheng Huang
    Jianying Zhou
    Cell Biochemistry and Biophysics, 2014, 70 : 553 - 558
  • [5] Efficacy and safety evaluation of icotinib in patients with advanced non-small cell lung cancer
    Aiqin Gu
    Chunlei Shi
    Liwen Xiong
    Tianqing Chu
    Jun Pei
    Baohui Han
    ChineseJournalofCancerResearch, 2013, 25 (01) : 90 - 94
  • [6] Clinical pharmacokinetics, safety, and preliminary efficacy evaluation of icotinib in patients with advanced non-small cell lung cancer
    Liu, Dongyang
    Zhang, Li
    Wu, Yiwen
    Jiang, Ji
    Tan, Fenlai
    Wang, Yingxiang
    Liu, Yong
    Hu, Pei
    LUNG CANCER, 2015, 89 (03) : 262 - 267
  • [7] Association between Icotinib Efficacy and Circulating Tumor Cell Levels in Advanced Non-Small Cell Lung Cancer
    Huang, Y.
    Wang, W.
    Xu, C.
    Zhuang, W.
    Song, Z.
    Huang, Z.
    Lin, G.
    Chen, X.
    Wu, B.
    Chen, Y.
    Chen, G.
    Fang, M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2203 - S2203
  • [8] Efficacy of Icotinib treatment in patients with stage IIIb/IV non-small cell lung cancer
    Qin, Na
    Yang, Xinjie
    Zhang, Quan
    Li, Xi
    Zhang, Hui
    Lv, Jialin
    Wu, Yuhua
    Wang, Jinghui
    Zhang, Shucai
    THORACIC CANCER, 2014, 5 (03) : 243 - 249
  • [9] Apatinib plus icotinib in treating advanced non small cell lung cancer after icotinib treatment failure: a retrospective study
    Xu, Jianping
    Liu, Xiaoyan
    Yang, Sheng
    Zhang, Xiangru
    Shi, Yuankai
    ONCOTARGETS AND THERAPY, 2017, 10 : 4989 - 4995
  • [10] EFFICACY AND SAFETY OF ANLOTINIB COMBINED WITH ICOTINIB IN THE TREATMENT OF ADVANCED NON-SMALL-CELL LUNG CANCER
    Chen, Hualin
    Luo, Yiping
    Lin, Muwen
    Peng, Xiaoxia
    Liu, Meilian
    Huang, Zhong
    Wang, Yongcun
    Li, Shujun
    Yang, Donghong
    Yang, Zhixiong
    ACTA MEDICA MEDITERRANEA, 2022, 38 (03): : 2035 - 2040
12345